Menu
Not yet recruiting NCT07316946

Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial

No phase Interventional Shoulder Pain

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Experimental Group, Placebo Group.
Who it may be relevant to
Registry conditions: Shoulder Pain. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Spain
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial

Detailed description

Randomized clinical trial 2 arms

Interventions

  • Other Experimental Group
    The experimental group will receive a multilayer neuromuscular taping application using kinesiotape, consisting of the placement of two longitudinal strips in the direction of the lower trapezius, applied with tension close to 100% of the tape's elastic capacity. During the application, participants will be asked to activate the scapular depressor and retractor muscles. Additionally, two other longitudinal strips will be applied from the anterior portion of the humeral head toward the scapular
  • Other Placebo Group
    The placebo group will receive the same taping, with an identical arrangement of the strips, but without applying any tension (0%) to them. In addition, participants will not receive any instructions regarding muscle activation during the application. This placebo taping model has been used in previous studies, supporting its methodological validity.

Primary outcome measures

  • Actual Pain Intensity [Time frame: Baseline, after 30 minutes of the intervention and 72 hours after intervencion]
  • Pain Intensity during the arm elevation [Time frame: Baseline, 30 minutes after intervention and 72 hours after intervention]
Secondary outcome measures (3)
  • Static Scapular Position [Time frame: Baseline, 30 minutes after intervention and 72 hours after intervention]
  • Range of Motion [Time frame: Baseline, 30 minutes after intervention and 72 hours after intervention]
  • Functional Capacity [Time frame: Baseline, 30 minutes after intervention and 72 hours after intervention]

Eligibility criteria

Inclusion criteria

  • age over 18 years
  • compete in a sport that involves overhead movement patterns
  • train at least 2 hours per week
  • shoulder pain lasting more than six weeks
  • shoulder pain related to sports activity
  • understand Spanish fluently enough to complete the questionnaire assessment.

Exclusion criteria

  • presence of red flags that could suggest fractures, dislocations, or complete tendon ruptures, among others
  • neurological pathologies
  • other severe pathologies such as inflammatory arthritis, frozen shoulder
  • having received corticosteroid injections or physiotherapy treatment in the last six months
  • presence of previous surgeries
  • pregnancy
  • cognitive deficits that could limit the comprehension of the questionnaires or the physical evaluation
  • skin problems that would be a contraindication for any type of bandage.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Other

Study locations

Spain · 1 center
  • Faculty of Health Sciences — Soria

Identifiers

NCT: NCT07316946 · REF CEIm

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗